Heartflow, Inc.

Filing Date

Aug 7, 2025

Transaction Date

Aug 7, 2025

Accession Number

0001628280-25-039110

Form Type

3

Footnotes

1. (F1)The number of shares of common stock and exercise price, as applicable, give effect to the 1-for-2.92 reverse stock split of Heartflow, Inc.'s ("Heartflow") common stock, which became effective on July 31, 2025.
2. (F2)The option is vested and exercisable as to 4,993 shares, and the remaining shares will vest and become exercisable in monthly installments until November 8, 2025, subject to continued service through the applicable vesting date.
3. (F3)The option is vested and exercisable as to 19,972 shares, and the remaining shares will vest and become exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.
4. (F4)The option is vested and exercisable as to 22,981 shares, and the remaining shares will vest and become exercisable in monthly installments until October 30, 2027, subject to continued service through the applicable vesting date.
5. (F5)The option is vested and exercisable as to 28,811 shares, and the remaining shares will vest and become exercisable in monthly installments until December 16, 2028, subject to continued service through the applicable vesting date.
6. (F6)Represents the outstanding principal amount of a convertible promissory note held by Mr. Verghese, which will automatically convert upon consummation of Heartflow's initial public offering into shares of common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. These shares of common stock issuable upon conversion of the convertible promissory note have no expiration date.